Literature DB >> 22885563

Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

Paul W Jones1, Guy Brusselle, Roberto W Dal Negro, Montse Ferrer, Peter Kardos, Mark L Levy, Thierry Perez, Juan José Soler Cataluña, Thys van der Molen, Lukasz Adamek, Norbert Banik.   

Abstract

BACKGROUND: Most patients with chronic obstructive pulmonary disease (COPD) in Europe are treated in primary care, but perceptions on what guides primary care physicians (PCPs) in managing patients are lacking. AIMS: To describe factors associated with the assessment by PCPs of COPD severity and those associated with impaired health status, as assessed by patient-reported outcomes.
METHODS: This cross-sectional study evaluated health-related quality of life (HRQL) in 2,294 COPD patients from five European countries. The severity of COPD was clinically judged by the PCPs and GOLD stage severity was calculated using spirometry data.
RESULTS: PCPs' categories of severity reflected a wider range of HRQL scores (St George's Respiratory Questionnaire (SGRQ) total score: mild 30.3; moderate 41.7; severe 55.0; very severe 66.1) than GOLD severity grading (Stage I 38.2; Stage II 41.1; Stage III 49.9; Stage IV 58.5). Multiple ordinal logistic regression models showed that factors most closely related to PCP-rated COPD severity were Medical Research Council (MRC) dyspnoea grade, forced expiratory volume in 1 second (FEV₁) percent predicted, HRQL score (either SGRQ or COPD Assessment Test (CAT)), and previous hospitalisations (model generalised R²=0.45 or 0.44 (SQRQ or CAT in model, respectively); all factors p<0.0001). Factors with the highest association with HRQL scores (SGRQ or CAT) were MRC dyspnoea grade, COPD severity (PCP-rated), sputum production, and number of co-morbidities (model R²=0.46 or 0.37 (SQRQ or CAT in multiple linear regression model, respectively); all factors p<0.0001).
CONCLUSIONS: PCPs successfully graded COPD severity clinically and appeared to have greater discriminative power for assessing severity in COPD than FEV₁-based staging. Their more holistic approach appeared to reflect the patients' HRQL rating and was consistent across five European countries.

Entities:  

Mesh:

Year:  2012        PMID: 22885563      PMCID: PMC6547962          DOI: 10.4104/pcrj.2012.00065

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  34 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  COPD in Japan: the Nippon COPD Epidemiology study.

Authors:  Yoshinosuke Fukuchi; Masaharu Nishimura; Masakazu Ichinose; Mitsuru Adachi; Atsushi Nagai; Takayuki Kuriyama; Keiji Takahashi; Koichi Nishimura; Shinichi Ishioka; Hisamichi Aizawa; Carol Zaher
Journal:  Respirology       Date:  2004-11       Impact factor: 6.424

3.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease.

Authors:  D E O'Donnell; M Lam; K A Webb
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  The prevalence of COPD: using smoking rates to estimate disease frequency in the general population.

Authors:  P Stang; E Lydick; C Silberman; A Kempel; E T Keating
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

5.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

6.  Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice.

Authors:  Martine Hoogendoorn; Talitha L Feenstra; Tjard R J Schermer; Arlette E Hesselink; Maureen P M H Rutten-van Mölken
Journal:  Respir Med       Date:  2006-01       Impact factor: 3.415

7.  Interpretation of quality of life scores from the St George's Respiratory Questionnaire.

Authors:  M Ferrer; C Villasante; J Alonso; V Sobradillo; R Gabriel; G Vilagut; J F Masa; J L Viejo; C A Jiménez-Ruiz; M Miravitlles
Journal:  Eur Respir J       Date:  2002-03       Impact factor: 16.671

8.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.

Authors:  V S Peña; M Miravitlles; R Gabriel; C A Jiménez-Ruiz; C Villasante; J F Masa; J L Viejo; L Fernández-Fau
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

Review 9.  Detection of asthma and chronic obstructive pulmonary disease in primary care.

Authors:  C P van Schayck; N H Chavannes
Journal:  Eur Respir J Suppl       Date:  2003-01

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more
  21 in total

1.  For better or for worse: a longitudinal study on dyadic coping and quality of life among couples with a partner suffering from COPD.

Authors:  Isabelle Vaske; Maximiliane Florentine Thöne; Kerstin Kühl; Daniel Christian Keil; Wolfgang Schürmann; Winfried Rief; Nikola Maria Stenzel
Journal:  J Behav Med       Date:  2015-07-09

Review 2.  Drugs for chronic obstructive pulmonary disease.

Authors:  Christine Jenkins
Journal:  Aust Prescr       Date:  2017-02-01

3.  Identification of Anxiety Symptom Clusters in Patients with COPD: Implications for Assessment and Treatment.

Authors:  Jessica Y Breland; Natalie E Hundt; Terri L Barrera; Joseph Mignogna; Nancy J Petersen; Melinda A Stanley; Jeffery A Cully
Journal:  Int J Behav Med       Date:  2015-10

4.  Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.

Authors:  Patrícia Rebelo; Ana Oliveira; Cátia Paixão; Carla Valente; Lília Andrade; Alda Marques
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-29

5.  Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease.

Authors:  Cristina Esquinas; Maria A Ramon; Alexa Nuñez; Jesús Molina; José A Quintano; Miguel Roman-Rodríguez; Karlos Naberan; Carl Llor; Carlos Roncero; Marc Miravitlles; Miriam Barrecheguren
Journal:  Qual Life Res       Date:  2019-10-31       Impact factor: 4.147

6.  Management of Cough in Patients with Chronic Obstructive Pulmonary Disease: Results of the Multicenter Randomized Placebo-Controlled Clinical Trial.

Authors:  Sergey N Avdeev; Alexander A Vizel; Vladimir N Abrosimov; Andrey A Zaicev; Galina L Ignatova; Rustem F Khamitov; Marina P Mikhaylusova; Julia S Shapovalova; Elena F Pavlysh; Basil I Trofimov; Alexander V Emelyanov; Tatiana I Martynenko; Vladimir A Martynenko; Natalia E Kostina; Danila A Chizhov; Olga Yu Chizhova; Natalia A Kuzubova; Elena V Makova; Ekaterina V Makarova
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-05

7.  SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe.

Authors:  Matjaž Fležar; Karina Jahnz-Różyk; Gloria Enache; Tatiana Martynenko; Peter Kristufek; Sanda Škrinjarić-Cincar; Pavla Kadlecová; Goran Martinovic
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-10-09

8.  Development of the Diaphragmatic Paralysis Questionnaire: a simple tool for patient relevant outcome.

Authors:  Nils Jurriaan Kosse; Wolfram Windisch; Aris Koryllos; Alberto Lopez-Pastorini; Denis Piras; Hans-Willi Schroiff; Stephan Eric Straßmann; Erich Stoelben; Sarah Bettina Schwarz
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

Review 9.  Symptom variability in COPD: a narrative review.

Authors:  Jose Luis Lopez-Campos; Carmen Calero; Esther Quintana-Gallego
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-05-07

10.  Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study.

Authors:  Roberto W Dal Negro; Luca Bonadiman; Paola Turco
Journal:  Multidiscip Respir Med       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.